These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27513271)

  • 1. Molecular prevalence and antibiotics resistance pattern of class A bla CTX-M-1 and bla TEM-1 beta lactamases in uropathogenic Escherichia coli isolates from Pakistan.
    Rahman H; Naeem M; Khan I; Khan J; Haroon M; Bari F; Ullah R; Qasim M
    Turk J Med Sci; 2016 Apr; 46(3):897-902. PubMed ID: 27513271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.
    Goyal A; Prasad KN; Prasad A; Gupta S; Ghoshal U; Ayyagari A
    Indian J Med Res; 2009 Jun; 129(6):695-700. PubMed ID: 19692752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
    Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M
    J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and Molecular Characterization of CTX-M Type B-Lactamases in Gram Negative Bacterial Strains Isolated from Hospitals, Lahore, Pakistan.
    Saleem M; Rashid F; Liaqat I; Liaqat I; Ulfat M; Sultan A; Faiz M; Eijaz S; Bibi A
    J Oleo Sci; 2022; 71(6):875-879. PubMed ID: 35661068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of
    Abrar S; Ain NU; Liaqat H; Hussain S; Rasheed F; Riaz S
    Antimicrob Resist Infect Control; 2019; 8():80. PubMed ID: 31139363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgrouping of ESBL-producing Escherichia coli from animal and human sources: an approach to quantify the distribution of ESBL types between different reservoirs.
    Valentin L; Sharp H; Hille K; Seibt U; Fischer J; Pfeifer Y; Michael GB; Nickel S; Schmiedel J; Falgenhauer L; Friese A; Bauerfeind R; Roesler U; Imirzalioglu C; Chakraborty T; Helmuth R; Valenza G; Werner G; Schwarz S; Guerra B; Appel B; Kreienbrock L; Käsbohrer A
    Int J Med Microbiol; 2014 Oct; 304(7):805-16. PubMed ID: 25213631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P; Garzón D; Mattar S
    Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of extensively drug resistant and extended spectrum beta lactamases (ESBLs) producing uropathogenic Escherichia coli isolated from Faisalabad, Pakistan.
    Ehsan B; Haque A; Qasim M; Ali A; Sarwar Y
    World J Microbiol Biotechnol; 2023 Mar; 39(5):132. PubMed ID: 36959469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
    Abrar S; Vajeeha A; Ul-Ain N; Riaz S
    Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia.
    Tawfik AF; Alswailem AM; Shibl AM; Al-Agamy MH
    Microb Drug Resist; 2011 Sep; 17(3):383-8. PubMed ID: 21612509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008.
    Qi C; Pilla V; Yu JH; Reed K
    Diagn Microbiol Infect Dis; 2010 May; 67(1):87-91. PubMed ID: 20227224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and identification of extended spectrum β-lactamases (ESBL) in Escherichia coli isolated from a tertiary care hospital in North-East India.
    Ravikant ; Kumar P; Ranotkar S; Zutshi S; Lahkar M; Phukan C; Saikia KK
    Indian J Exp Biol; 2016 Feb; 54(2):108-14. PubMed ID: 26934778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community onset of CTX-M extended spectrum β-lactamases among uropathogenic E. coli and K. pneumoniae from Karachi, Pakistan.
    Fatima S; Muhammad IN; Khan MN; Jamil S; Siddiqui T; Khatoon H
    Pak J Pharm Sci; 2019 Mar; 32(2):541-546. PubMed ID: 31081764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of extended-spectrum beta-lactamase and class 1 integron integrase gene intl1 in Escherichia coli from Thai patients and healthy adults.
    Pongpech P; Naenna P; Taipobsakul Y; Tribuddharat C; Srifuengfung S
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):425-33. PubMed ID: 18564681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel.
    Chmelnitsky I; Carmeli Y; Leavitt A; Schwaber MJ; Navon-Venezia S
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4745-50. PubMed ID: 16251320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.
    Munday CJ; Whitehead GM; Todd NJ; Campbell M; Hawkey PM
    J Antimicrob Chemother; 2004 Sep; 54(3):628-33. PubMed ID: 15294889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from fecal samples of piglets with diarrhea in central and southern Taiwan in 2015.
    Lee WC; Yeh KS
    BMC Vet Res; 2017 Mar; 13(1):66. PubMed ID: 28249582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic susceptibility pattern and identification of extended spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae from Shiraz, Iran.
    Mansury D; Motamedifar M; Sarvari J; Shirazi B; Khaledi A
    Iran J Microbiol; 2016 Feb; 8(1):55-61. PubMed ID: 27092225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.